# SILDENAFIL CITRATE
> **ANDA211534** · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2020-05-29
## Drug
- **FDA Application Number:** ANDA211534
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SILDENAFIL CITRATE
- **Generic name:** SILDENAFIL
- **Active ingredients:** SILDENAFIL CITRATE
- **Dosage form:** FOR SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** TEVA PHARMS USA
- **Manufacturer:** Actavis Pharma, Inc.
- **First approval:** 2020-05-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211534)
---
*AI Analytics · CC0 1.0*